AURKB and cancer: AZD 1152, another selective inhibitor of AURKB, was also able to inhibit the growth of different human cancer xenografts including that of the lung, via suppression of histone H3 phosphorylation, accumulation of 4N DNA in cells and increased proportion of polyploid cells.